Back to Search
PAUL RICHARDSON, M.D.
M.D.
Internal Medicine Physician
NPI: 1972596005Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
23051(SC)
Research & Publications (20)
Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma.
PMID 19471019·Blood·2009
3-trial
The effects of flexible bronchoscopy on mechanical ventilation in a pediatric lung model.
PMID 18812449·Chest·2009
8-other
TRPC4 in rat dorsal root ganglion neurons is increased after nerve injury and is necessary for neurite outgrowth.
PMID 17928298·J Biol Chem·2008
7-preclinical
Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma.
PMID 18297527·Leuk Lymphoma·2008
3-trial
The emerging role of novel therapies for the treatment of relapsed myeloma.
PMID 17335684·J Natl Compr Canc Netw·2007
6-review
Optimizing the efficacy and safety of bortezomib in relapsed multiple myeloma.
PMID 16830422·Clin Adv Hematol Oncol·2006
8-other
Can thalidomide improve outcome in patients with multiple myeloma?
PMID 17080171·Nat Clin Pract Oncol·2006
8-other
Optimizing bortezomib treatment in patients with relapsed multiple myeloma.
PMID 16832859·Clin Adv Hematol Oncol·2006
8-other
Bortezomib: proteasome inhibition as an effective anticancer therapy.
PMID 16409135·Annu Rev Med·2006
6-review
Newer treatment options for patients in first relapse. From the Multiple Myeloma Research Foundation.
PMID 16773847·Oncology (Williston Park)·2006
5-case
Bortezomib: proteasome inhibition as an effective anticancer therapy.
PMID 16555986·Future Oncol·2005
6-review
New therapies for the treatment of multiple myeloma.
PMID 16167007·Clin Adv Hematol Oncol·2005
8-other
Novel biological therapies for the treatment of multiple myeloma.
PMID 16026741·Best Pract Res Clin Haematol·2005
6-review
Assembly of lipoprotein particles containing apolipoprotein-B: structural model for the nascent lipoprotein particle.
PMID 15653747·Biophys J·2005
7-preclinical
Management of the relapsed/refractory myeloma patient: strategies incorporating lenalidomide.
PMID 16344100·Semin Hematol·2005
6-review
Emerging trends in the clinical use of bortezomib in multiple myeloma.
PMID 16231845·Clin Lymphoma Myeloma·2005
6-review
Bortezomib: a novel therapy approved for multiple myeloma.
PMID 16258456·Clin Adv Hematol Oncol·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2367B CYPRESS CIR
CONWAY, SC 29526 - Phone
- (843) 349-1001
Quick Facts
- NPI
- 1972596005
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile